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ABSTRACT. We prospectively investigated uri-
nary iodine concentration (UIC) in pregnant wom-
en and in female, non-pregnant controls in the
canton of Berne, Switzerland, in 1992. Mean UIC
of pregnant women [205±151 μg iodine/g crea-
tinine (μg I/g Cr); no.=153] steadily decreased
from the first (236±180 μg I/g Cr; no.=31) to the
third trimester (183±111 μg I/g Cr, p<0.0001;
no.=66) and differed significantly from that of
the control group (91±37 μg I/g Cr, p<0.0001;
no.=119). UIC increased 2.6-fold from levels in-
dicating mild iodine deficiency in controls to the
first trimester, demonstrating that high UIC dur-
ing early gestation does not necessarily reflect a
sufficient iodine supply to the overall population.
Pregnancy is accompanied by important alter-
ations in the regulation of thyroid function and
iodine metabolism. Increased renal iodine clear-
ance during pregnancy may explain increased
UIC during early gestation, whereas increased
thyroidal iodine clearance as well as the iodine
shift from the maternal circulation to the growing
fetal-placental unit, which both tend to lower the
circulating serum levels of inorganic iodide, prob-
ably are the causes of the continuous decrease
of UIC over the course of pregnancy. Mean UIC
in our control group, as well as in one parallel
and several consecutive investigations in the
same region in the 1990s, was found to be below
the actually recommended threshold, indicating
a new tendency towards mild to moderate io-
dine deficiency. As salt is the main source of di-
etary iodine in Switzerland, its iodine concentra-
tion was therefore increased nationwide in 1998
for the fourth time, following increases in 1922,
1965 and 1980.
(J. Endocrinol. Invest. 26: 389-396, 2003)
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INTRODUCTION
Dietary iodine supply, usually assessed by measur-
ing urinary iodine concentration (UIC), has received
considerable attention worldwide (1, 2). About one
fifth of Earth’s population is at risk of iodine defi-
ciency (ID), 200-300 million people present with dis-
turbed thyroid function or a goiter caused by ID,
about 20 million suffer from ID-induced mental re-
tardation and about 6 million are cretins (3). Goiter
is endemic in most European countries, and a rec-
ommended minimal iodine supply of 150 μg/day
for adults and of 175-200 μg/day for pregnant
women (4) [or a urinary concentration of 150 μg io-
dine/g creatinine (μg I/g Cr) and 175-200 μg I/g Cr,
respectively, assuming a mean 24 h urinary creati-
nine excretion of 1.0 g in women (5)] is achieved
only in a few regions (6, 7). Thyroid disorders
caused by ID range from discrete functional distur-
bances to mild intellectual impairment to full-blown
cretinism (8, 9). 
In pregnant women, a tendency towards an in-
crease of TSH within physiological limits was ob-
served even under conditions of only mild to mod-
erate ID (with UIC of 50-100 μg iodine/day [μg I/d])
(10, 11). Continuous monitoring of a group at risk of
developing latent hypothyroidism under conditions
of marginal iodine supply, such as pregnant wom-
en, is essential (10, 11). 
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The goal of the present study was to evaluate ran-
dom individual and sequential UIC data of preg-
nant women in the Bernese region in Switzerland
in 1992, in order to compare them with data in the
literature. Determining UIC levels of pregnant wom-
en in Switzerland seemed an important topic of re-
search, especially since UIC levels which had been
shown to be adequate in Switzerland in the 1980s
appeared to be moderately insufficient in the 1990s
in the same region (12-14). This insufficiency prob-
ably reflects a decrease in dietary iodine supply,
and is assumed to be due to changes in nutritional
habits (12, 13).
MATERIAL AND METHODS
Subjects
From the end of February to early April 1992 we investigated
UIC and urinary creatinine concentration (UCC) in spot urine
samples of 192 pregnant women from six different regions in
the canton of Berne, Switzerland (Interlaken, Heimberg,
Burgdorf, Biel, Thun and Berne) and of 124 healthy, non-preg-
nant women from the regions of Berne (no.=71) and Burgdorf
(no.=53) who served as controls. 
After written informed consent was obtained, gynecologists
and general practitioners collected spot urine samples of con-
secutive pregnant (at any stage of pregnancy) and non-preg-
nant women, respectively, on the occasion of routine consul-
tations at various times of the day. The samples were collect-
ed in conventional 10 ml plastic tubes and frozen immediate-
ly (no.= 50, 66, and 76 samples from the first, second and third
trimesters, respectively). Significant circadian (15) and season-
al (16) rhythms of UIC, with higher UIC values in late afternoon
compared to early morning and during winter compared to
summer, were not reported in the medical literature until af-
ter the sampling period, and thus were not taken into consid-
eration in the study design.
All women completed a questionnaire on preexisting thyroid
diseases, consumption of iodized vs non-iodized salt at home,
special diets, intake of medicines (in particular multiple vitamins
or oligoelements) and exposure to contrast media or other io-
dine-containing pharmaceuticals. 
In order to confirm the low initial UIC values of part of the Berne
control group and to exclude a transiently insufficient supply,
36 non-pregnant control women with values <100 μg I/l were
reevaluated (= Berne repetition) in November 1992.
The results of the group of pregnant women from the region of
Burgdorf were confusing. The mean UIC values of this group
(859±504 μg I/g Cr; or 583±345 μg I/l; no.=27, p<0.001) signif-
icantly exceeded those of all other groups. 85% of the values
exceeded 300 μg I/g Cr, and 44% even exceeded 1000 μg I/g
Cr. There were no differences regarding the socio-demograph-
ic characteristics, results from the questionnaires and UCC com-
pared with the groups from other regions. Perineal or vaginal
disinfecting with an iodine-containing solution at the gynecolo-
gist’s was ruled out. When an evaluation of healthy, non-preg-
nant women in Burgdorf one year later (91±42 μg I/g Cr; or
95±73 μg I/l; no.=50) revealed a mean UIC in line with the val-
ues of the non-pregnant women from the region of Berne, we
assumed a transient and short-term iodine contamination of un-
known origin and excluded the whole Burgdorf group of preg-
nant women from the calculations. 
After exclusion of extreme UIC values (see statistics), a total of
153 spot urine samples from pregnant women (no.=31, 56 and
66 in the first, second and third trimesters, respectively) and of
119 samples from non-pregnant women remained. In order to
compare our UIC findings with data from the literature, we cal-
culated the mean UIC (and not medians, as used in other epi-
demiological studies) of the groups. Though the controls were
not matched for age, the pregnant women (29.7±4.4 yr) and the
controls (27.8±5.6 yr) did not differ significantly. 
In accordance with previously published studies (10, 17-20),
pregnancy was divided arbitrarily into weeks 1-16, 17-29, and
30 to delivery, corresponding to the first, second and third
trimesters, respectively. Of the 50 pregnant women who had
been included during the first trimester, 34 and 31 women col-
lected a further urine sample during the second and third
trimesters, respectively. In 15 women, UIC could be studied se-
quentially (one urine sample from each trimester). 
Analytical methods 
All laboratory analyses were performed at the Division of Clinical
Chemistry, Inselspital, University of Berne, Switzerland. Total io-
dine was determined using the wet ash method based on the
Sandell-Kolthoff reaction (21) and with the same Technicon
Autoanalyzer (Technicon, Tarrytown, NY) used in previous stud-
ies in this region since 1975 (13, 22, 23). Creatinine was deter-
mined with a Hitachi 911 Autoanalyzer (Boehringer, Mannheim,
Germany) using the picric acid method of Jaffé. A detailed de-
scription of the analytical methods has been given previously
(14, 24). The method used in the present study for iodine mea-
surement gives results closely comparable to a modified Sandell-
Kolthoff procedure (24), which again correlates very well with a
method using inductively coupled plasma mass spectrometry
(25). The iodine/creatinine ratio in urine samples was shown to
provide a reliable estimation of iodine intake (26) and has been
used in literature on urinary iodine measurements. Since the re-
nal clearances of iodine and creatinine are altered to the same
extent in pregnancy, the iodine/creatinine ratio represents a
valid parameter for longitudinal studies of urinary iodine con-
centration during gestation (27, 28). 
Statistics
The results were analyzed statistically using t test. Extreme val-
ues were identified by the formula T=(x-d)/ Standard deviation
(SD), in which x = presumptive extreme value, d = mean value
of the group without x, and SD without x. Provided there is a
normal distribution, T will have a maximum value of 3.402 with-
in groups of 30 members, for a level of significance of 99%. 
RESULTS
UIC in pregnant women
As summarized in Table 1, the mean ±SD UIC of
all pregnant women (205±151 μg I/g Cr; or
204±202 μg I/l; no.=153) differed significantly
from the control group (91±37 μg I/g Cr or 91±68
μg I/l; p<0.0001; no.=119). Except for the group
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from the region of Thun, every single group of
pregnant women differed significantly from the
control group. Age, preexisting thyroid diseases
and diets did not influence UIC. None of the study
participants declared an intake of pre-natal food-
stuffs or of pharmaceuticals with known relevant
iodine contents.
The mean UIC increased 2.6-fold during the first
trimester compared with the control group and
thereafter steadily decreased from the first
(236±180 μg I/g Cr; or 267±317 μg I/l; no.=31) to
the second (213±170 μg I/g Cr; or 206±175 μg I/l;
no.=56) and the third (183±111 μg I/g Cr; or
172±138 μg I/l; p<0.0001; no.=66) trimester. The
median (range) values (extreme values not exclud-
ed) were 85 (24-575) μg I/g Cr (no.=124) for the
controls and 183 (46-5335) μg I/g Cr (no.=36), 153
(69-729) μg I/g Cr (no.=59) and 143 (58-2205) μg
I/g Cr (no.=67) for the first, second and third
trimester, respectively. 
This pattern was confirmed in the spot urine samples
from the 15 sequentially studied women, with a sig-
nificant decrease of mean UIC from the first (258±192
μg I/g Cr; or 325±353 μg I/l) to the third trimester
(153±70 μg I/g Cr; or 183±121 μg I/l; p<0.0001),
while UCC remained unchanged (Table 2). 
Distribution of the UIC data
Although the mean UIC of all pregnant women ex-
ceeded the recommended lower threshold of 175
-200 μg I/g Cr (4), 96 values (63%) were found be-
low this limit and 28 values (18%) were found in the
range of 50-100 μg I/g Cr. Thirty one (20%) and
twenty-nine (19%) of the pregnant women com-
pared to zero and three (3%) of the non-pregnant
women had UIC data above 300 μg I/g Cr and 300
μg I/l urine, respectively. Five, three and one of the
excluded extreme UIC values from pregnant wom-
en were from the first, second and third trimester,
respectively (see statistics and Table 1).
Table 1 – Urinary iodine concentration of pregnant and non-pregnant women from various regions in the canton of Berne, Switzerland. 
Region N (2) UIC UCC Single extreme values (6)
μg I/g Cr mmol/l μg I/g Cr
mean ± 1 SD mean ±1 SD (see statistics)
Berne 69 91±34 9.3±6.0 343; 305
Burgdorf (1) 50 91±42 10.3±7.1 575; 439; 260
Controls, all (2) 119 91±37 9.7±6.5
Interlaken 28 142±71(4) 8.6±5.3 (3) 916; 532
Thun 29 103±30 (3) 8.9±5.0 (3) 208
Heimberg 35 236±163 (5) 9.1±5.1 (3) 5335; 2205; 1845
Biel 27 160±52 (5) 6.9±2.7 (4) 958; 569; 428
Berne 34 346±184 (5) 10.6±5.4 (4) None
Pregnant, all (2) 153 205±151 (5) 8.9±5.0 (3)
(1) Urine samples collected one year after those from Berne. (2) Without extreme values (see statistics). Significance vs controls: (3) not significant, 4)
p<0.001, (5) p<0.0001. (6) Excluded from calculations. UIC = urinary iodine concentration, UCC = urinary creatinine concentration, μg I/g Cr = μg iodine/g
creatinine. To convert UCC from mmol/l to g/l divide by 8.840. 
Table 2 – Urinary iodine concentration and urinary creatinine concentration in the course of pregnancy and in controls.
N (1) UIC UCC
μg I/l urine μg I/g Cr mmol/l
mean ±1 SD mean ±1 SD mean ±1 SD
Control group 119 89±63 91±37 9.7±6.5
Individual samples
1st trimester 31 267±317 (3) 236±180 (3) 9.2±5.6 (2)
2nd trimester 56 206±175 (3) 213±170 (3) 9.1±5.0 (2)
3rd trimester 66 172±138 (3,4) 183±111 (3,4) 8.6±4.6 (2)
Sequential samples
1st trimester 15 325±353 258±192 10.4±7.2
2nd trimester 15 166±100 183±82 8.4±4.8 
3rd trimester 15 183±121 (4) 153±70 (4) 10.0±3.7
(1) Numbers of samples after exclusion of extreme values (see statistics and Table 1). Significance vs controls: (2) none, (3) p<0.0001. Significance vs 1st
trimester: (4) p<0.0001. Trimesters 1, 2 and 3 denote weeks 1-16, 17-29 and 30 to delivery, respectively. UIC = urinary iodine concentration, UCC = urinary
creatinine concentration, μg I/l urine = μg iodine/l urine, μg I/g Cr = μg iodine/g creatinine. To convert UCC from mmol/l to g/l divide by 8.840.
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DISCUSSION
In the Bernese region, where mild ID prevailed, UIC
in 153 pregnant women was found to be signifi-
cantly higher than in a control group of non-preg-
nant women. Compared to the controls, the UIC
during the first trimester of pregnancy increased
2.6-fold and decreased progressively over the sec-
ond to the third trimester. However, even in the
third trimester, UIC values were still significantly
higher in pregnant women than in non-pregnant
controls.
UIC throughout pregnancy
As summarized in Fig. 1, the available data from
the literature suggest an increased mean UIC dur-
ing gestation, unless the mean UIC in the reference
populations is below approximately 75 μg I/g Cr
(or <75 μg I/l urine).
Under conditions of severe ID in a region of former
Eastern Germany (mean UIC 21±14 μg I/g Cr in
non-pregnant women aged 18-35 yr), mean UIC
values in mid- and late gestation were found to be
lower than those of the respective controls (columns
A and C in Fig. 1) (17, 18). This was also true after
improvement of iodine supply to about 50-75
μg/day [mean UIC in the control group estimated
from Fig. 2 in reference (18) at about 70 μg I/g Cr,
indicating moderate ID]. In a small group from an-
other severely iodine-deficient region in Italy (not
shown in Fig. 1), UIC during pregnancy was found
to be clearly below that of the control population
(29±16 μg I/g Cr; no.=16 vs 49±43 μg I/g Cr; level
of significance not reported) (29). One study per-
formed in Denmark (not shown in Fig. 1) and one
study from Belgium (columns B in Fig. 1), both with
a mean UIC of about 50-75 μg I/day (or 50-75 μg I/l
urine) in the respective reference populations, re-
vealed an unchanged UIC during pregnancy (10,
30, 31). In two Irish populations with a UIC of
80±1.6 μg I/l and 94±6.8 μg I/g Cr in the non-preg-
nant controls, UIC throughout pregnancy was sig-
nificantly increased in comparison with the respec-
tive controls (columns D and E in Fig. 1) (19, 20). In
a region of Iran with a comparably high UIC of
about 200 μg I/l in the controls, UIC during preg-
nancy did not differ significantly from non-pregnant
women (not shown in Fig. 1) (32). 
UIC in early gestation (1st trimester)
The mean UIC in the present study was found to
be highly significantly increased during the first
trimester (236±180 μg I/g Cr) compared with the
control group (91±37 μg I/g Cr; columns F in Fig.
1). Similar results have been reported from Ireland,
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Fig. 1 - In studies with a mean UIC in the controls above approximately 75 μg I/l urine or μg I/g Cr (columns D, E, F), mean UIC dur-
ing pregnancy is increased. In studies with a mean UIC in the controls below approximately 75 μg I/l urine or μg I/g Cr (columns A,
B, C), mean UIC during pregnancy remains stable or even decreases. Mean urinary iodine concentration of the control group Bauch
1993 was estimated from Figure 2 in reference (18). Data comparison between the different authors and regions is limited, since val-
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vs respective controls:  *p<0.05; **p<0.01; ***p<0.0001.
URINARY IODINE CONCENTRATION DURING GESTATION
Comparison of own data with the literature [according to Banch 1993 (18), extended]
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where in two different studies a mean UIC of
148±6 μg I/g Cr (control group 80±1.6 μg I/g Cr,
p<0.001; columns D in Fig. 1) and 176±18 μg I/g
Cr (control group 94±7 μg I/g Cr, p<0.01; columns
E in Fig. 1) were found in the first trimester (19,
20). Under conditions of mild to severe ID, UIC in
the first trimester was reported to increase slight-
ly (no level of significance reported) in another
study (columns A in Fig. 1) (17). The exact UIC val-
ues of the control populations of two other stud-
ies (columns B and C in Fig. 1) from regions with
mild ID are not available (UIC in the control group
about 50-75 μg I/g Cr) (10, 18). 
Decrease of UIC in the 2nd and 3rd trimesters
In our sequentially studied urine samples of 15
women, the mean UIC decreased significantly from
the first to the third trimesters, while the mean UCC
remained unchanged (Table 2). As summarized in
Fig. 1, UIC decreased in the course of pregnancy
in the present and in most of the previously pub-
lished investigations (10, 18, 19, 20). In a large
group of pregnant women from Belgium (not
shown in Fig. 1), a similar decreasing shift from
58±2 μg I/l in early gestation to 49±2 μg I/l in late
gestation was reported (33). 
The increase of UIC in early gestation as well as the
decrease during the course of pregnancy probably
reflects two major physiological changes. 
First, with pregnancy, renal clearance of iodide in-
creases significantly due to an increased glomeru-
lar filtration rate (27, 28). This iodide loss tends to
lower the circulating levels of inorganic iodide and
induces, in turn, a compensatory increase in the thy-
roidal iodide clearance (11, 27, 34). The rapid post-
partum return of UIC to pre-pregnant values docu-
mented in the literature is probably due to normal-
ization of renal clearance as well as placental loss,
and suggests a direct effect of pregnancy on uri-
nary iodine output (11, 17, 19, 20). In areas with
moderate ID, serum inorganic iodide levels de-
crease already during early gestation (11, 27). This
may explain why in such regions mean UIC through-
out pregnancy does not increase or even decreas-
es as compared to that of non-pregnant women
(10, 17, 18, 29, 30).
Second, later on during gestation, a part of the
available iodide pool is shifted from the maternal
circulation to the expanding fetal-placental unit (11,
35), leading to an additional, progressive decrease
of circulating levels of inorganic iodide. The in-
creased thyroidal iodide clearance and the shift to
the fetal-placental unit may explain the observa-
tions of progressive UIC decrease during gestation.
To our knowledge, there are no available data con-
cerning the existence and location of an active reg-
ulation system of renal retention or secretion of
halogens and especially of iodide.
High individual UIC values during pregnancy
In the present study, the mean UIC of all preg-
nant women exceeded the recommended lower
threshold of 175-200 μg I/g Cr (4). One-fifth of
the pregnant women compared to zero of the
non-pregnant women had UIC values above 300
μg I/g Cr. Nevertheless, two-thirds of the UIC val-
ues from pregnant women did not reach the 175
μg I/g Cr threshold and one-fifth was even found
to be in the low range of 50-100 μg I/g Cr. The
existence of high intra-individual variability (13),
as well as the significant relevance of a circadian
rhythm of UIC (15), was unknown in 1992 when
the urinary samples for the present study were
collected. We cannot exclude that urine spots in
the controls might have been sampled more of-
ten during morning hours, whereas pregnant
women might have sampled throughout the day.
As UIC has been found to be lower in the morn-
ing than in the afternoon, this potential method-
ological bias may represent an additional expla-
nation for the higher frequency of high and some-
times very high UIC data in pregnant women
compared with the controls. 
In another Swiss study performed after salt iodide
concentration had been increased in 1998, i.e., un-
der different baseline conditions than in the pre-
sent study, roughly one-fifth of 511 pregnant wom-
en [estimated from Fig. 2 in reference (36)] had a
UIC above 300 μg I/l throughout pregnancy. In this
study 13% of all pregnant women declared con-
sumption of an iodine-containing supplement (36)
compared to none in the present investigation.
Higher mean UIC values in early compared to late
gestation are unlikely to result from a method-
ological bias, as the UIC pattern throughout preg-
nancy found in the random individual (expressed
as mean and median values) as well as in the se-
quential samples were closely comparable. Since
UIC decreases in the course of pregnancy, and be-
cause mid- (no.=56/153) and late- (no.=66/153)
gestational periods were somewhat over-repre-
sented in our sample series, the average UIC over
the whole pregnancy as well as the average UIC
during the first trimester could likely have shifted
to even higher values in a numerically more bal-
anced study population. 
Pregnancy and iodine metabolism
Pregnancy constitutes a challenge for both the
maternal and fetal thyroid glands and induces ma-
L. Brander, C. Als, H. Buess, et al.
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jor alterations of iodine metabolism (11, 37). Two
excellent and comprehensive surveys concerning
regulation of thyroid function during pregnancy
have been published (11, 35). The increased fre-
quency of goiter during or after pregnancy has
repeatedly been confirmed (10, 11, 20, 30, 38).
The pathogenesis of goiter has also been dis-
cussed in detail recently (39-41). Thyroid disor-
ders are observed four- to five-fold more fre-
quently in women than in men (11). Whether thy-
roid stimulation during gestation is causal and suf-
ficient to explain later development of au-
tonomous thyroid growth and function in women
is still unknown. 
Iodine supplementation during pregnancy
In regions with mild to severe ID, supplementation
by iodine or by iodine plus L-thyroxine during preg-
nancy prevented an increase of the thyroid volume
in the mothers and the newborns and attenuated
or suppressed an increase of maternal TSH levels
in several published studies (17, 30, 31). One sin-
gle study, however, reported an increase of thyroid
volumes in pregnant women despite supplemen-
tation by 300 μg I/d and no effect on the maternal
TSH levels (42). It might be possible that these con-
tradictory results are due to a lack of compliance in
some of the subjects (as UIC data in a quarter of
the treated pregnant women remained very low) or
to the higher supplementation dose in comparison
with other studies.
The available literature does not definitely answer
questions on the optimal dose, timing, or duration
of iodine supplementation with relation to preg-
nancy. Whether it is beneficial to give iodine sup-
plements to pregnant women under conditions of
only borderline ID remains unknown and requires
further evaluation. Nevertheless, since a tendency
towards an increase of TSH levels arises even un-
der conditions of only mild to moderate ID (with
UIC of 50-100 μg I/d) in pregnant women (10, 11),
iodine supplementation (with 150-200 μg I/d) dur-
ing pregnancy should seriously be considered, at
least until a sufficient level of UIC has been docu-
mented in women of child-bearing age within the
population. It cannot be stressed enough that even
if children have UIC levels indicating sufficient io-
dine supply, women of child-bearing age in the
same population may present UIC indicating sig-
nificant ID (43).
Low UIC in the control group
After table salt in Switzerland had been supple-
mented with increasing concentrations of potas-
sium iodide in 1922, 1965 and 1980 (with 5, 10
and 20 mg/kg, respectively), urinary iodine con-
centration rose from less than 30 μg I/24 h in
1920 to a UIC of more than 150 μg I/g Cr in the
1980s, indicating sufficient supply (23). However,
average UIC in our control group of 119 non-
pregnant women (91±37 μg I/g Cr) was in good
agreement with data from a parallel investigation
of adults (87±40 μg I/g Cr; no.=54) (12), with two
later studies in the same region (15) and in dif-
ferent parts of Switzerland (44, 45), indicating a
new tendency towards mild to moderate ID, es-
pecially in young female adults (43). Because in
the present study UIC values of some non-preg-
nant women from Berne (Berne repetition) were
confirmed unchanged by a second measurement
seven months after the initial collection, a tran-
siently insufficient iodine supply could be ruled
out. Only 6% of our individual values reached the
recommended threshold of 150 μg I/g Cr (4), and
as much as 8% of the values were found to be be-
low 50 μg I/g Cr. 
Two potential biases may be ruled out. The UCC
of our controls did not differ from previous investi-
gations in the same region (46), and a seasonal vari-
ation of UIC related to the intake of milk and fresh
milk products was shown to be significant only in
children, who have a high milk intake, but not in
adult women, who consume much less milk (16). 
As a consequence, given that in Switzerland salt is still
the main source of dietary iodine, supplementation
was increased nationwide in 1998 for the fourth time. 
CONCLUSIONS
In conclusion, UIC during early pregnancy increas-
es under conditions of mild to moderate ID and de-
creases from early to late gestation. These varia-
tions are caused by physiological adaptations of
thyroid and renal clearances of iodide. Therefore, as
UIC during pregnancy does not necessarily reflect
the actual iodine supply, interpretation of UIC dur-
ing pregnancy has to be performed with caution.
The question of which UIC threshold in pregnant
women reliably reflects sufficient iodine supply re-
quires further evaluation. 
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